Euroapi SAS Total Liabilities
Euroapi SAS total liabilities. Based on the latest financial reports, Euroapi SAS (EAPI) has total liabilities worth €771.40 Million EUR (≈ $901.85 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EAPI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Euroapi SAS (2019–2025)
Total liabilities of Euroapi SAS from 2019 to 2025. This chart illustrates how Euroapi SAS's total liabilities have evolved over time, based on quarterly financial data.
Euroapi SAS Competitors by Total Liabilities
The table below lists competitors of Euroapi SAS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WINS Co. Ltd
KQ:136540
|
Korea | ₩23.42 Billion |
|
INITECH Co. Ltd
KQ:053350
|
Korea | ₩7.10 Billion |
|
United Bancorp Inc
NASDAQ:UBCP
|
USA | $805.88 Million |
|
Hana Financial 7 SPAC
KQ:230240
|
Korea | ₩119.33 Billion |
|
ST Dupont
PA:DPT
|
France | €30.70 Million |
|
FM Global Logistics Holdings Bhd
KLSE:7210
|
Malaysia | RM439.04 Million |
|
AMCON Distributing Company
NYSE MKT:DIT
|
USA | $282.10 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Euroapi SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Euroapi SAS.
Liquidity & Leverage Metrics
Euroapi SAS Total Liabilities Ratios Explained
Euroapi SAS total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Euroapi SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Euroapi SAS (2019–2025)
The table below shows the annual total liabilities of Euroapi SAS from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €516.70 Million ≈ $604.08 Million |
+2.11% |
| 2024-12-31 | €506.00 Million ≈ $591.57 Million |
-26.10% |
| 2023-12-31 | €684.70 Million ≈ $800.49 Million |
+9.39% |
| 2022-12-31 | €625.90 Million ≈ $731.74 Million |
+3.11% |
| 2021-12-31 | €607.00 Million ≈ $709.65 Million |
-0.75% |
| 2020-12-31 | €611.60 Million ≈ $715.02 Million |
+9.49% |
| 2019-12-31 | €558.60 Million ≈ $653.06 Million |
-- |
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; … Read more